To compare the CIMP classifications derived from our clustering analysis to those derived from the Weisenberger panel of genes [4], we analysed the methylation status of our tumour samples using MethyLight [18] at each gene from this panel (CACNA1G, NEUROG1, SOCS1, IGF2, RUNX3). The gene discussed is IGF2; the disease is neoplasm.